Richard Schlenker
Analyst · William Blair & Company
Thanks, Paul. We are very pleased with our financial results for the fourth quarter, closing another strong year in 2011.
For the fourth quarter, revenues before reimbursements or net revenues, as I will refer to them from hereon, increased 11% to $60.5 million as compared to $54.6 million in the prior year period. Total revenues for the quarter increased 8% to $67.9 million as compared to $62.6 million in 2010. Net income for the fourth quarter increased 25% to $7.7 million or $0.54 per diluted share. EBITDA in the quarter increased 20% to $14.1 million.
For the full year 2011, net revenues increased 11% to $246.7 million. Total revenues increased 10% to $272.4 million. Net income for the year improved 19% to $32.7 million or $2.22 per diluted share. EBITDA in 2011 improved 16% to $59 million.
In our defense technology development business, net revenues for the fourth quarter were $4.4 million, including $1.3 million for product sales. For the full year, net revenues were $17.3 million, including $4.2 million for product sales.
In 2012, we expect net revenues from product sales to be approximately the same as in 2011. But as a reminder, product sales are very lumpy in nature and vary significantly from quarter-to-quarter.
For the first quarter of 2012, we expect net revenues from product sales to be $650,000 as compared to $2.5 million in the first quarter of 2011.
As Paul discussed, utilization in the fourth quarter was 69%, which was exceptionally strong considering the impact of holidays and vacations have on the quarter.
For the year, utilization was 71%. In 2012, we expect utilization to be lower by a percentage point or 2 as a result of several major assignments stepping down in their level of activity over the next several quarters.
Contributing to strong utilization in the fourth quarter was a 10% increase in billable hours to -- totaling $243,000. This brings the full year total to 981,000 hours, which is up 9% as compared to 2010.
During 2011, we also realized an effective billing rate increase of 2.7%. For 2012, our new billing rates took effect on January 1. We expect to realize a billing rate increase of approximately 3%, based on an average billing rate increase for existing staff of approximately 4.25%, which has historically been reduced by hiring of more junior staff throughout the year.
Our average technical full-time equivalent employees for the fourth quarter increased 7% to 677 as compared to the same period last year. For the full year, average FTEs were 661, up 7% from 2010. We are very pleased with the talent we have added this year, which includes new Ph.D.s from top schools, as well as several senior hires. We will continue to selectively hire key talent to expand our capabilities, as this is the key to our long-term organic growth strategy.
For 2012, we expect sequential quarterly growth of FTEs to be approximately 1% per quarter. The percentages I will reference hereafter are on a percentage of net revenue basis.
EBITDA margin for the fourth quarter improved 190 basis points to 23.4%, up from 21.5% in the same period last year. EBITDA margin for the year improved 100 basis points to 23.9%, up from 22.9% in 2010. These notable increases are the result of improved utilization and effective cost management.
For the fourth quarter, compensation expense after adjusting for gains and losses and deferred compensation, increased 9% to $38.2 million. For the full year 2011, compensation expense, again after adjusting for gains and losses and deferred compensation, increased 8% to $157.1 million. These increases are the result of 7% headcount growth and annual compensation increases.
As a reminder, our annual raises occur in April of each year, and are expected to be at or below our average billing rate increase.
Included in total compensation in the fourth quarter is gains to deferred compensation of $1.4 million as compared to $1 million last year. For 2011, gains and losses and deferred compensation was a loss or a contra expense of $280,000 as compared to a gain or expense of $1.9 million in 2010. As a reminder, deferred compensation gains and losses are offset in miscellaneous income and have no impact on the bottom line.
Also as a component of compensation, stock-based compensation expense for the fourth quarter was $2.1 million and the full-year was $10.3 million. In 2012, we expect stock-based compensation to be approximately $11.5 million for the full year. Approximately $4.25 million will be expensed in the first quarter. Consistent with prior years, this higher level of expense in the first quarter is the result of a requirement to accelerate expensing of our matching RSU grants to employees over the age of 59.5.
Other operating expenses for the fourth quarter increased 8% over the prior year to $5.9 million. As a component of other operating expense, depreciation was $1.2 million. For the full year, other operating expenses were up 9% to $23.2 million as compared to 2010. Depreciation expense was $4.4 million in 2011, up slightly from 2010. For 2012, we expect other operating expenses to be in the range of $6 million to $6.5 million per quarter.
G&A expenses in the fourth quarter were $3.8 million, about flat with the same period last year. For the year, G&A expenses increased 6% to $13.1 million as compared to 2010. For 2012, we expect G&A expense to be in the range of $3.1 million to $3.4 million in the first 3 quarters, and then approximately $3.8 million in the fourth quarter.
For the year, interest income was $236,000 as compared to $198,000 in 2010. Our tax rate for the fourth quarter of 2011 was 40.9% as compared to 42.2% in the same period last year. For 2011, our tax rate was 40.3% compared to 41.1% in 2010. For 2012, we expect our tax rate to be approximately 40.3%.
Turning to the balance sheet. For the year, we generated $46.6 million in cash from operations, and used $40.6 million to repurchase 1 million shares of our stock at an average price of $40.50, closing the year with $109.7 million of cash, cash equivalents and short-term investments.
At the close of 2011, we had $9.4 million still available for repurchases and expect further authorization from our board when this is extinguished.
Capital expenditures for the fourth quarter were $1.2 million or -- and were $3.8 million for the full year. DSOs were 92 days at the end of the year.
In summary, we are very pleased with how the firm executed in 2011. We were able to assist more than 1,500 clients, over 7,000 projects during the year, utilizing over 90 different disciplines. While our largest projects in 2011 accounted for a greater percentage of our revenues than in a typical year, we are most excited about the growth we saw across a broad set of our practices and the strength of our market position.
Looking to the first quarter of 2012, we are expecting net revenue growth in the low single digits and EBITDA margin declining 150 to 200 basis points, considering the significant hurdle of the first quarter of 2011.
There are 3 factors, in addition to any step down in major projects, that will impact our year-over-year net revenue comparison and margins.
First, product sales to be down $2 million or 3% of net revenues. We do expect that this decline in product sales will be made up for over the next 3 quarters.
Secondly, our handling fee on reimbursable expenses will be down $750,000 or 1.2% of net revenue. This was higher in 2011 as we were procuring a significant amount of materials for the U.K. GPR project.
And lastly, we have one more holiday because of the timing of New Year's, which will have a 1.5% impact on net revenues.
For the full year 2012, we expect growth in net revenues to be in the low- to mid-single digits. This growth has been tempered by the fact that our largest projects in 2011 accounted for a greater percentage of our revenues than in a typical year. As a result, we expect 2012 utilization to be lower by a percentage point or 2 as compared to last year, and EBITDA margin will be down slightly.
Now I will turn the call back to Paul for concluding remarks.